Pancreaze and Spiriva drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pancreaze and Spiriva. Common interactions include hypertension among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people who take Pancreaze and Spiriva have. It is created by eHealthMe based on reports of 6 people who take Pancreaze and Spiriva from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 30, 2022

6 people who take Pancreaze and Spiriva together, and have interactions are studied.


What is Pancreaze?

Pancreaze has active ingredients of pancrelipase (amylase;lipase;protease). eHealthMe is studying from 753 Pancreaze users for its effectiveness, alternative drugs and more.

What is Spiriva?

Spiriva has active ingredients of tiotropium bromide monohydrate. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 146,202 Spiriva users for its effectiveness, alternative drugs and more.

Number of Pancreaze and Spiriva reports submitted per year:

Pancreaze and Spiriva drug interactions.

Common Pancreaze and Spiriva drug interactions by gender *:

female:

  1. Hypertension
  2. Neuropathy peripheral
  3. Pancreatic carcinoma
  4. Peripheral vascular disorder
  5. Transient ischaemic attack
  6. Pneumonia
  7. Blindness
  8. Blindness unilateral
  9. Carbon monoxide poisoning
  10. Glaucoma

male:

  1. Diarrhoea
  2. Fall
  3. Muscle spasms
  4. Neuropathy peripheral
  5. Restless legs syndrome

Common Pancreaze and Spiriva drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Carbon monoxide poisoning
  2. Pneumonia
  3. Transient ischaemic attack

* Approximation only. Some reports may have incomplete information.

Do you take Pancreaze and Spiriva?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Pancreaze and Spiriva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Spiriva side effects:

Browse all side effects of Spiriva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Pancreaze interactions:

Browse all interactions between Pancreaze and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Spiriva interactions:

Browse all interactions between Spiriva and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on pancrelipase (amylase;lipase;protease) and tiotropium bromide monohydrate (the active ingredients of Pancreaze and Spiriva, respectively), and Pancreaze and Spiriva (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Pancreaze and Spiriva.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: